Results 71 to 80 of about 95,168 (297)

Clinical progress note: Hepatitis A virus

Journal of Hospital Medicine, EarlyView.
Abstract Despite a decline in hepatitis A virus (HAV) incidence following vaccine introduction, HAV remains a public health concern in the United States. Recent multi‐state outbreaks have demonstrated that HAV can re‐emerge and highlight inequities in vaccine coverage or access, outbreak response, and in those with social or health risk factors ...
James M. McCluskey III, Robyn A. Bockrath, Ravi Jhaveri   +2 more
wiley   +1 more source

Pulmonary immunization: deposition site is of minor relevance for influenza vaccination but deep lung deposition is crucial for hepatitis B vaccination

Acta Pharmaceutica Sinica B, 2019
Vaccination via the pulmonary route could be an attractive alternative to parenteral administration. Research towards the best site of antigen deposition within the lungs to induce optimal immune responses has conflicting results which might be dependent
Jasmine Tomar, Wouter F. Tonnis, Harshad P. Patil, Anne H. de boer, Paul Hagedoorn, Rita Vanbever, Henderik W. Frijlink, Wouter L.J. Hinrichs   +7 more
doaj   +1 more source

Serological immunity against vaccine‐preventable diseases in children with inflammatory bowel disease at diagnosis

JPGN Reports, EarlyView.
Abstract Objectives Patients with inflammatory bowel disease (IBD) are at increased risk of vaccine‐preventable diseases. However, vaccination coverage in this population is often suboptimal. This retrospective study assessed the vaccination status and vaccine serology of children diagnosed with IBD in a high‐income country with broad vaccine access ...
Clara Noble, Renato Gualtieri, Klara Posfay‐Barbe, Nathalie Rock, Geraldine Blanchard‐Rohner   +4 more
wiley   +1 more source

Hepatitis B Virus (HBV) Vaccine in Pregnancy and Impact on Pregnancy Outcome [PDF]

, 2018
Deborah L. Covington, S Kaydo, K.M. Veley   +2 more
openalex   +1 more source

Identification of Clinical Factors Associated With the Immunogenicity of Homologous ChAdOx1‐nCoV‐19 Vaccine in Hemodialysis Patients

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Hemodialysis (HD) patients are at higher risk of severe COVID‐19 and may exhibit suboptimal vaccine responses. This study evaluates the factors influencing vaccine‐induced immunity in HD patients following the second dose of the Vaxzevria. A total of 276 HD patients and 126 controls were included. Antibody responses were assessed using binding
Chia‐Wei Chang, Ping‐Hsun Wu, Li‐Yun Chang, Yu‐Ying Huang, Teng‐Hui Huang, Su‐Chu Lee, Yi‐wen Chiu, Shang‐Jyh Hwang, Tsun‐Yung Kuo, Mei‐Chuan Kuo   +9 more
wiley   +1 more source

Knowledge, awareness, attitude, and practice of health-care professionals toward hepatitis B disease and vaccination in Saudi Arabia

Human Vaccines & Immunotherapeutics, 2019
Objectives: Health-care professionals (HCPs) are at very high risk for accidental exposure to hepatitis B virus (HBV) from infected patients; as such, this study aimed to investigate the knowledge, awareness, attitude, and practice of HCPs toward ...
Thamir M. Alshammari, Mohamad Aljofan, Gehad Subaie, Talib Hussain   +3 more
doaj   +1 more source

Beyond PD‐1/PD‐L1: New Immune Checkpoints and Therapeutic Combinations in Cancer Immunotherapy

Medicine Bulletin, EarlyView.
ABSTRACT Recently, immune checkpoint inhibitors (ICIs), particularly PD‐1/PD‐L1 and CTLA‐4 inhibitors, have revolutionized cancer treatment, significantly improving survival rates for various malignancies. However, ICI therapies targeting single checkpoints on T cells still face numerous challenges, such as low response rates and post‐treatment ...
Yangyang Li, Zizhen Kang, Yanyun Du
wiley   +1 more source

Evaluación de la inmunogenicidad de una vacuna recombinante antivirus hepatitis B en mujeres adultas sanas, Santafé de Bogotá, D.C., julio 1997 - noviembre 1998

Biomédica: revista del Instituto Nacional de Salud, 1999
Este estudio se realizó con el propósito de evaluar la inmunogenicidad de la vacuna recombinante antivirus de la hepatitis B HEPRECOMB BERNABy el desarrollo de efectos secundarios atribuibles a la vacuna y a la vía de aplicación, empleando y comparando ...
María T. Herrera Mendoza, Jaime Escobar López, Clara l. Saavedra Abril, Claudia P. Robles Roa, Fritz Gempele, Eduardo Egea Bermejo, Antonio Iglesias Gamarra   +6 more
doaj   +1 more source

Towards Comprehensive Chronic Disease Control: Prevention, Early Detection, and Integrated Management

Medicine Bulletin, EarlyView.
ABSTRACT Chronic non‐communicable diseases (NCDs), including cardiovascular disease, diabetes, cancer, and chronic respiratory conditions, represent the leading causes of morbidity and mortality worldwide. This review examines comprehensive strategies across the continuum of care (from primary prevention and early screening to timely diagnosis ...
Ping Sun, Zhengwei Wan, Yuping Liu
wiley   +1 more source

Progress in coverage with hepatitis B vaccine among US children, 1994-1997. [PDF]

, 1999
H. Yusuf, Victor G. Coronado, F A Averhoff, E F Maes, Lance E. Rodewald, Maurizio Battaglia, Francis J. Mahoney   +6 more
openalex   +1 more source